CAM
Cormorant Asset Management’s Avidity Biosciences RNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.68M | Sell |
200,000
-200,000
| -50% | -$5.68M | 0.42% | 37 |
|
|
2025
Q1 | $11.8M | Sell |
400,000
-650,000
| -62% | -$19.2M | 0.89% | 27 |
|
|
2024
Q4 | $30.5M | Hold |
1,050,000
| – | – | 1.68% | 17 |
|
|
2024
Q3 | $48.2M | Buy |
1,050,000
+625,000
| +147% | +$28.7M | 2.56% | 11 |
|
|
2024
Q2 | $17.4M | Buy |
+425,000
| New | +$17.4M | 1% | 30 |
|
|
2023
Q4 | – | Sell |
-1,762,115
| Closed | -$11.2M | – | 54 |
|
|
2023
Q3 | $11.2M | Sell |
1,762,115
-850,000
| -33% | -$5.42M | 0.66% | 33 |
|
|
2023
Q2 | $29M | Hold |
2,612,115
| – | – | 1.62% | 15 |
|
|
2023
Q1 | $40.1M | Sell |
2,612,115
-150,000
| -5% | -$2.3M | 2.64% | 10 |
|
|
2022
Q4 | $61.3M | Buy |
2,762,115
+750,000
| +37% | +$16.6M | 4.1% | 5 |
|
|
2022
Q3 | $32.9M | Hold |
2,012,115
| – | – | 2.3% | 14 |
|
|
2022
Q2 | $29.2M | Hold |
2,012,115
| – | – | 2.21% | 12 |
|
|
2022
Q1 | $37.2M | Hold |
2,012,115
| – | – | 2.85% | 11 |
|
|
2021
Q4 | $47.8M | Sell |
2,012,115
-150,000
| -7% | -$3.57M | 2.84% | 10 |
|
|
2021
Q3 | $53.3M | Sell |
2,162,115
-66,552
| -3% | -$1.64M | 2.16% | 14 |
|
|
2021
Q2 | $55.1M | Sell |
2,228,667
-235,878
| -10% | -$5.83M | 1.87% | 11 |
|
|
2021
Q1 | $53.8M | Sell |
2,464,545
-2
| -0% | -$44 | 1.2% | 18 |
|
|
2020
Q4 | $62.9M | Sell |
2,464,547
-49,999
| -2% | -$1.28M | 1.5% | 19 |
|
|
2020
Q3 | $69.5M | Sell |
2,514,546
-1
| -0% | -$28 | 2.67% | 6 |
|
|
2020
Q2 | $67.8M | Buy |
+2,514,547
| New | +$67.8M | 2.59% | 8 |
|